Preparing for the Next Zika – Nature Biotechnology

Read article - In this commentary, Kendall Hoyt, asst. professor of medicine at Geisel, and Richard Hatchett, acting director of the Biomedical Advanced Research and Development Authority in Washington, DC, suggest lessons from the U.S. biodefense program should inform international efforts to build a medical countermeasure enterprise for emerging infectious diseases.